About: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$8.40 (-0.47%)
AVR ASX Anteris Technologies Global Corp
Anteris Technologies Global Corp share price
AVR price activity
Last Price
$8.400
Change (24hr)
-0.04 AUD (0.47%)
Volume
306
Volume (4w avg)
-
Open
$8.40
Day Range
$8.22 - $8.40
Previous Close
$8.44
Last Trade
26 Oct, 5:10 am GMT+0
Delayed
26 Oct, 5:10 am GMT+0
AVR price performance
Delayed
26 Oct, 5:10 am GMT+0
AVR Market Signals